✦ LIBER ✦

Hematopoietic stem cell transplantation for childhood myeloid malignancies after high-dose thiotepa, busulfan and cyclophosphamide

✍ Scribed by Worth, L L; Tran, H; Petropoulos, D; Culbert, S C; Mullen, C A; Roberts, W M; Przepiorka, D; Chan, K W

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early-onset secondary malignancies after

✍ S. Fetscher; J. Finke; R. Engelhardt; R. Mertelsmann; W. Lange 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 140 KB

High-dose thiotepa and hematopoietic ste

✍ Lafay-Cousin, L; Hartmann, O; Plouvier, P; Méchinaud, F; Boutard, P; Oberlin, O 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 55 KB

ototoxicity after high-dose chemotherapy

✍ AP Jillella; GW Britt; MS Litaker; AM Kallab; K Harkness; GD Garner 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 482 KB

Idiopathic pneumonia syndrome after high

✍ Wong, R; Rondon, G; Saliba, R M; Shannon, V R; Giralt, S A; Champlin, R E; Ueno, 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 136 KB

High-dose melphalan versus busulfan, cyc

✍ Don M. Benson Jr.; Patrick J. Elder; Thomas S. Lin; William Blum; Sam Penza; Bel 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Prognostic factors for disease progressi

✍ Popat, U; Hosing, C; Saliba, R M; Anderlini, P; Besien, K van; Przepiorka, D; Kh 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 167 KB